Cardiol Therapeutics Inc.
OAKVILLE, A6 · Founded 2017 · CIK 0001702123 · Biotech · Public
Anti-inflammatory and anti-fibrotic therapeutic compounds for heart disease
cardiolrx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $6.0M
- 5 Form D · Nov 2025
- 11 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 7
- 1 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $55,658 | |
| Private capital raised | Form D · SEC | $680,000 | |
| Private capital raised | Form D · SEC | $3,662,260 | |
| Private capital raised | Form D · SEC | $829,139 | |
| Private capital raised | Form D · SEC | $760,000 |
Form D · SECPress
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1878 | STEMBIOSYS, INC. | — | $3.4M |
| 1879 | Prince Biotech, Inc. | — | $10M |
| 1880 | TBC II LLC | — | $3.5M |
| 1881 | Cardiol Therapeutics Inc. | — | $6.0M |
| 1882 | IMMUNO NANO MED, INC | — | — |
| 1883 | MycoRx LLC | — | $600K |
| 1884 | Biosplice Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Press
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in ProceedsPRNewswire
Founders & Team
- Anthony BoltonDirector · Executive Officer · Promoter
- Deborah BrownDirector
- Iain ChalmersDirector
- Jennifer ChaoDirector
- David ElsleyDirector · Executive Officer · Promoter
- Tim GarnettDirector
- Andrew HamerExecutive Officer
- Bernard LimExecutive Officer
- Teri LoxamDirector
- Terrance LynchDirector
- Terry LynchDirector
- Thomas MoffattExecutive Officer
- Peter PekosDirector
- Eldon SmithDirector · Executive Officer · Promoter
- Colin StottDirector
- Dr. Guillermo Torre-AmioneDirector
- Guillermo Torre-AmioneDirector
- Chris WaddickDirector · Executive Officer
Patents
- Cannabidiol Compositions For Use In Treating Heart Conditionsapplication
- Cannabidiol Compositions For Use In Treating Heart Conditionsgranted
- Stable Injectable Cannabidiol Formulationsapplication
- Cannabidiol For Use In Treating Or Preventing Recurrent Pericarditisapplication
- Stable Oral Cannabidiol Compositionsapplication
- Stable Medicinal Cannabidiol Compositionsapplication
- Amphiphilic Block Copolymers, Micelles, And Methods For Treating Or Preventing Heart Failureapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.